Accordingly, plasmatic lipocalin-2, a glycoprotein involved in several obesity-related conditions as well as chronic inflammatory processes was found to be elevated in MS but not in partial or total GHD (55). This evidence concerns the gene LCN2 and myeloid sarcoma.